News & Events
-
Congressional Testimony 2003
FDA Statements
-
November
- 11/20/2003
Drug Importation
John M. Taylor, III, Associate Commissioner for Regulatory Affairs, Food and Drug Administration, before the Senate Committee on Commerce, Science and Transportation - 11/19/2003
Vaccine Research
Lester M. Crawford, D.V.M, Ph.D., Deputy Commissioner of Food and Drugs, before the Senate Committee on Governmental Affairs - 11/13/2003
Dietary Supplements
William Egan, Acting Director, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, before the Senate Committee on Government Reform
-
-
October
- 10/28/2003
Dietary Supplements: Protecting Americans from Potential Adverse Health Risks
John M. Taylor, Associate Commissioner for Regulatory Affairs Food and Drug Administration, before the Senate Committee on Commerce - 10/23/2003
Federal and State Role in Pharmacy Compounding and Reconstitution: Exploring the Right Mix to Protect Patients
Steven K. Galson, M.D., M.P.H., Acting Director of the Food and Drug Administration before the Senate Committee on Health, Education, Labor and Pensions
-
-
August
- 08/01/2003
Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments)
Daniel E. Troy, Chief of Counsel of the Food and Drug Administration before the Committee on Judiciary
-
-
July
- 07/24/2003
Ephedrine Alkaloid-Containing Dietary Supplements
Mark B. McClellan, M.D., Ph.D., before the Senate Subcommittee on Commerce, Trade and Consumer Protection and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce - 07/24/2003
Counterterrorism Activities
Mark B. McClellan, M.D., Ph.D., before the Committee on Health, Education, Labor, and Pensions - 07/22/2003
Regulating Prescription Drug Promotion
Janet Woodcock, M.D., before the Senate Special Committee on Aging - 07/17/2003
FDA's Role in the National Response to an Emerging zoonotic or Secondarily Transmitted Infectious Disease
Lester M. Crawford, D.V.M, Ph.D., before the Committee on Environment and Public Works - 07/10/2003
Collaborative Efforts to Facilitate Cancer Drug Development
Theresa M. Mullin, Ph.D, before the House Committee on Energy and Commerce, Subcommittee on Health - 07/09/2003
Technology and Innovation: Their Effects on Cost Growth of Healthcare
Mark B. McClellan, M.D., Ph.D., before the Committee on Joint Economics
-
-
June
- 06/24/2003
Imported, Counterfeit, and Unapproved Drugs
John M. Taylor, III, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 06/17/2003
FTC Study: Generic Drug Entry Prior to Patent Expiration
Daniel E. Troy, before the Senate Committee on the Judiciary - 06/17/2003
Regulation of Foods Derived From Plants
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Agriculture, Subcommittee on Conservation, Credit, Rural Development, and Research - 06/12/2003
Safety of Prescription Drugs From Foreign Sources
William K. Hubbard, before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness
-
-
May
- 05/14/2003
Tissue Banks: The Dangers of Tainted Tissues and the Need for Federal Regulation
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Governmental Affairs - 05/07/2003
FDA Efforts to Combat the SARS Outbreak
Murray M. Lumpkin, M.D. M.Sc., before the House Committee on Energy and commerce, Subcommittee on Oversight and Investigations
-
-
April
- 04/03/2003
International Prescription Drug Parity
William K. Hubbard, before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness
-
-
March
- 03/27/2003
Benefits and Risks of the Sale of Drugs via the Internet
William K. Hubbard, before the House Committee on Government Reform - 03/10/2003
South Florida Access to Affordable Prescription Drugs: Costs and Benefits of Alternative Solutions
John M. Taylor, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 03/06/2003
FY 2004 FDA Budget Request
Mark B. McClellan, MD, Ph.D., before the House Committee
-
-
-